The University of Southampton
University of Southampton Institutional Repository

Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data.

Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data.
Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data.
Background: in Huntington’s disease (HD), it remains unclear how symptom severity and rate of symptomatic change relates to age and CAG repeat number (CAGn). It is often difficult for clinicians to assess whether an affected individual’s symptoms are progressing at a similar rate to their affected peers, limiting their ability to intervene at the most appropriate time.

Objective: to develop a clinical dashboard that compares an individual’s total motor score (TMS), total functional capacity (TFC) and symbol digit modality test (SDMT) scores against a global cohort, controlling for age and CAGn. The dashboard could then be used by clinicians to identify individuals progressing at a disproportionate rate to his or her peers.

Methods: annualised longitudinal clinical assessment scores from the Enroll-HD dataset were used to generate decline trajectories of the global cohort, allowing cross-sectional (TMS n = 734; TFC n = 734; SDMT n = 694) and longitudinal (TMS n = 270; TFC n = 270; SDMT n = 247) comparison with individual clinical symptom rating scores, to assess decline relative to affected peers.

Results: an electronic dashboard with a dynamic output display was created that rapidly compares clinical symptom rating scores of a specific individual against affected peers from a global cohort of comparable CAGn.

Conclusions: this study shows the potential for use of multi-centre trial data in allowing comparison of the individual to a larger group to facilitate improved decision-making for individual patients. Visualisation of these metrics via a clinical dashboard demonstrates how it may aid identification of those with disproportionate decline, offering potential for intervention at specific critical points in the disease course.
139-147
Walker, Thomas
4ad2e691-9a88-4cb1-b4d7-0ec3a4ac33ea
Ghosh, Boyd
f8e37115-eb7a-427b-ad2a-d1d5acb26552
Kipps, Christopher
e43be016-2dc2-45e6-9a02-ab2a0e0208d5
Walker, Thomas
4ad2e691-9a88-4cb1-b4d7-0ec3a4ac33ea
Ghosh, Boyd
f8e37115-eb7a-427b-ad2a-d1d5acb26552
Kipps, Christopher
e43be016-2dc2-45e6-9a02-ab2a0e0208d5

Walker, Thomas, Ghosh, Boyd and Kipps, Christopher (2017) Assessing decline: visualising progression in Huntington's disease using a clinical dashboard with Enroll-HD data. Journal of Huntington's Disease, 6 (2), 139-147. (doi:10.3233/jhd-170234).

Record type: Article

Abstract

Background: in Huntington’s disease (HD), it remains unclear how symptom severity and rate of symptomatic change relates to age and CAG repeat number (CAGn). It is often difficult for clinicians to assess whether an affected individual’s symptoms are progressing at a similar rate to their affected peers, limiting their ability to intervene at the most appropriate time.

Objective: to develop a clinical dashboard that compares an individual’s total motor score (TMS), total functional capacity (TFC) and symbol digit modality test (SDMT) scores against a global cohort, controlling for age and CAGn. The dashboard could then be used by clinicians to identify individuals progressing at a disproportionate rate to his or her peers.

Methods: annualised longitudinal clinical assessment scores from the Enroll-HD dataset were used to generate decline trajectories of the global cohort, allowing cross-sectional (TMS n = 734; TFC n = 734; SDMT n = 694) and longitudinal (TMS n = 270; TFC n = 270; SDMT n = 247) comparison with individual clinical symptom rating scores, to assess decline relative to affected peers.

Results: an electronic dashboard with a dynamic output display was created that rapidly compares clinical symptom rating scores of a specific individual against affected peers from a global cohort of comparable CAGn.

Conclusions: this study shows the potential for use of multi-centre trial data in allowing comparison of the individual to a larger group to facilitate improved decision-making for individual patients. Visualisation of these metrics via a clinical dashboard demonstrates how it may aid identification of those with disproportionate decline, offering potential for intervention at specific critical points in the disease course.

This record has no associated files available for download.

More information

Published date: 30 June 2017

Identifiers

Local EPrints ID: 489349
URI: http://eprints.soton.ac.uk/id/eprint/489349
PURE UUID: 69f89515-c6e6-43e2-bd58-7e286bed19c1
ORCID for Christopher Kipps: ORCID iD orcid.org/0000-0002-5205-9712

Catalogue record

Date deposited: 22 Apr 2024 16:37
Last modified: 21 Sep 2024 01:58

Export record

Altmetrics

Contributors

Author: Thomas Walker
Author: Boyd Ghosh
Author: Christopher Kipps ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×